Medtronic to Acquire Scientia Vascular in 2nd Deal of 2026

Medtronic to Acquire Scientia Vascular in 2nd Deal of 2026

On March 10, Medtronic announced its entry into a definitive agreement to acquire Scientia Vascular. The acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. Scientia Vascular is a private company operating in Salt Lake City, Utah, with approximately 310 employees. The company has developed access products that enable simplicity and access for physicians treating complex neurovascular conditions. Medtronic manufactures and sells device-based medical therapies worldwide, including spinal, cardiovascular and minimally invasive devices. For the fiscal year (FY) ending April 25, 2025, the company... Read More »
Tactile Systems Technology Buys LymphaTech for $6.8 Million Upfront

Tactile Systems Technology Buys LymphaTech for $6.8 Million Upfront

Tactile Systems Technology, Inc. announced that it is acquiring LymphaTech for an upfront cash payment at closing of $6.8 million, plus potential additional consideration that is contingent upon the achievement of future milestones. Founded in 2014, LymphaTech is a privately held medical technology company pioneering a digital, three-dimensional full body measurement and monitoring platform designed specifically for lymphedema. Tactile Systems Technology is a medical technology company focused on developing medical devices for the treatment of underserved chronic diseases at home. The company develops and markets at-home therapies for people suffering from underserved, chronic conditions,... Read More »
Medtronic to Acquire Scientia Vascular in 2nd Deal of 2026

TheraB Medical Announces Acquisition by Natus Sensory

TheraB Medical announced on February 11 that it has been acquired by Natus Sensory, an ArchiMed company. TheraB Medical is an East Lansing, Michigan-based innovator in wearable phototherapy technology for neonatal jaundice. Its flagship product, SnugLit, delivers comprehensive body coverage in the familiar form factor of an infant swaddle while eliminating the need for eye protection. Its design allows increased clinician and parent interaction, including breastfeeding, without interrupting therapy. TheraB received FDA 510(k) clearance in January 2026 and is backed by various individual angel investors and funds, including Red Cedar Ventures, Healthcare Equity Angels, Michigan Rise, Gulf... Read More »
DW Healthcare Partners Announces Sale of LKC Technologies to Ametek

DW Healthcare Partners Announces Sale of LKC Technologies to Ametek

DW Healthcare Partners, a healthcare-focused private equity firm, announced on February 3 the sale of LKC Technologies to Ametek, Inc. LKC Technologies will join Ametek as part of its Electronic Instruments Group.  LKC Technologies is a leading provider of technologies to enable the effective diagnosis and management of ophthalmic conditions. LKC Technologies develops portable devices that help doctors test and monitor eye health. These tools are designed to detect early signs of diabetic retinopathy and other serious eye conditions that can lead to vision loss. The company is headquartered in Germantown, Maryland. DW Healthcare Partners previously invested in LKC Technologies in June... Read More »
New Horizon Medical Solutions Acquires Applied Tissue Technologies’ Business Assets

New Horizon Medical Solutions Acquires Applied Tissue Technologies’ Business Assets

Even though we’re approaching the end of the year, the healthcare M&A market hasn’t dried up quite yet. On December 29, New Horizon Medical Solutions (NHMS) announced the acquisition of Applied Tissue Technologies’ (ATT) business assets. The sale of ATT’s assets includes a transparent negative pressure wound therapy device and micro grafting kit. ATT is a 25-year-old wound care company based in Boston, Massachusetts. The company has conducted research and development supported by the United States Department of Defense to help wounded warriors at the point of injury, in instances of prolonged field care and delayed evacuation and throughout advanced levels of military medical... Read More »
Blackstone and TPG Acquire Hologic in $18.3 Billion Deal 

Blackstone and TPG Acquire Hologic in $18.3 Billion Deal 

On October 20, TPG and Blackstone announced that they entered into a definitive agreement to acquire Hologic, Inc. The purchase represents an enterprise value of up to $18.3 billion.  Founded in 1985, Hologic develops, manufactures and sells premium diagnostic products, medical imaging systems and surgical products, primarily for women’s health. Hologic reported an annual revenue of more than $4 billion for its 2024 fiscal year, which ended on September 28, 2024.  TPG is a global alternative asset management firm. It was founded in San Francisco in 1992 and has $246 billion of assets under management.  Blackstone is the world’s largest alternative asset manager. The... Read More »